Literature DB >> 17363610

Sensitization of mesothelioma cells to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by heat stress via the inhibition of the 3-phosphoinositide-dependent kinase 1/Akt pathway.

Melissa H Pespeni1, Maki Hodnett, Keith S Abayasiriwardana, Jérémie Roux, Marybeth Howard, V Courtney Broaddus, Jean-François Pittet.   

Abstract

Heat stress may enhance the effect of apoptosis-inducing agents in resistant tumor cells. One such agent is the tumor necrosis factor-related apoptosis-inducing ligand (TRAIL), which has attracted intense interest for its ability to induce apoptosis in tumors without affecting nonmalignant cells. We therefore tested whether heat stress potentiates TRAIL-induced apoptosis in mesothelioma cells, its cell type being resistant to TRAIL alone. We found that heat stress enhanced the apoptosis caused by TRAIL but not by chemotherapy. To explain this potentiation, we found that heat stress decreased Akt phosphorylation via the dissociation of heat shock protein 90 (Hsp90) from its client protein 3-phosphoinositide-dependent kinase 1 (PDK-1), a major Akt kinase. The role of Hsp90 and the Akt pathway was confirmed by showing that inhibitors of Hsp90 and the phosphatidyilinositol-3 kinase/Akt pathway reproduced the effect of heat stress on TRAIL-induced apoptosis and that the effect of inhibiting Hsp90 on TRAIL-induced apoptosis could be overcome by activating the Akt pathway with a constitutively active construct of the Akt kinase PDK-1. The effect of heat stress involved multiple steps of the apoptotic machinery. Heat stress potentiated the death receptor pathway, as shown by an increase in TRAIL-induced caspase 8 cleavage. Nonetheless, knockdown of Bid, the main intermediary molecule from the death receptor pathway to the mitochondria, inhibited the effect of heat stress, showing that mitochondrial amplification was required for potentiation by heat stress. In summary, these results support the novel concept that heat stress inhibits the Akt pathway by dissociating PDK-1 from its chaperone Hsp90, leading to potentiation of TRAIL-induced apoptosis in resistant malignant cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17363610     DOI: 10.1158/0008-5472.CAN-06-3871

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  6 in total

1.  Transforming growth factor-β-induced protein (TGFBI) suppresses mesothelioma progression through the Akt/mTOR pathway.

Authors:  Gengyun Wen; Mei Hong; Bingyan Li; Wupeng Liao; Simon K Cheng; Burong Hu; Gloria M Calaf; Ping Lu; Michael A Partridge; Jian Tong; Tom K Hei
Journal:  Int J Oncol       Date:  2011-06-23       Impact factor: 5.650

2.  Activation of the stress protein response inhibits the STAT1 signalling pathway and iNOS function in alveolar macrophages: role of Hsp90 and Hsp70.

Authors:  Marybeth Howard; Jérémie Roux; Hyon Lee; Byron Miyazawa; Jae-Woo Lee; Brandi Gartland; Amanda J Howard; Michael A Matthay; Michel Carles; Jean-François Pittet
Journal:  Thorax       Date:  2010-04       Impact factor: 9.139

3.  Activation of the heat shock response attenuates the interleukin 1β-mediated inhibition of the amiloride-sensitive alveolar epithelial ion transport.

Authors:  Marybeth Howard; Jérémie Roux; Karen E Iles; Byron Miyazawa; Sarah Christiaans; Naseem Anjum; Dale A Dickinson; Arnaud Goolaerts; Michael A Matthay; Jean Francois Pittet
Journal:  Shock       Date:  2013-02       Impact factor: 3.454

4.  Activating Death Receptor DR5 as a Therapeutic Strategy for Rhabdomyosarcoma.

Authors:  Zhigang Kang; Shi-Yong Sun; Liang Cao
Journal:  ISRN Oncol       Date:  2012-04-17

5.  Sialic acid-binding lectin (leczyme) induces apoptosis to malignant mesothelioma and exerts synergistic antitumor effects with TRAIL.

Authors:  Takeo Tatsuta; Masahiro Hosono; Kohta Takahashi; Takashi Omoto; Yukiko Kariya; Shigeki Sugawara; Senitiroh Hakomori; Kazuo Nitta
Journal:  Int J Oncol       Date:  2013-11-28       Impact factor: 5.650

6.  Depletion of CABYR-a/b sensitizes lung cancer cells to TRAIL-induced apoptosis through YAP/p73-mediated DR5 upregulation.

Authors:  Qianqian Xiao; Zunlei Qian; Weiqing Zhang; Jin Liu; Enze Hu; Jinsan Zhang; Mingying Li; Junhao Wang; Fei Kong; Yunguang Li; Rui Wang; Xiaohua Tan; Dacheng He; Xueyuan Xiao
Journal:  Oncotarget       Date:  2016-02-23
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.